Employers Question Weight Loss Drug Coverage
This is a the United States news story, published by Yahoo, that relates primarily to Wegovy news.
the United States news
For more the United States news, you can click here:
more the United States newsWegovy news
For more Wegovy news, you can click here:
more Wegovy newsNews about health policy
For more health policy news, you can click here:
more health policy newsYahoo news
For more news from Yahoo, you can click here:
more news from YahooAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about
health insurance plans. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest health insurance news, health plan news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
health plansNBC News
•Fewer than 1 in 5 large companies' health plans cover weight loss drugs, survey finds
83% Informative
Less than a fifth of large companies in the United States include coverage for the popular but pricey weight loss drugs Wegovy and Zepbound in their health insurance plans.
A third say coverage has a “significant impact” on their plans' prescription drug spending.
About 154 million people get health insurance through their jobs.
VR Score
86
Informative language
84
Neutral language
66
Article tone
informal
Language
English
Language complexity
43
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
8
Source diversity
2
Affiliate links
no affiliate links